American Dollar to Canadian Dollar = 0.784280; American Dollar to Chinese Yuan = 0.152912; American Dollar to Euro = 1.225195; American Dollar to Japanese Yen = 0.009681; American Dollar to Mexican Peso = 0.050508.
https://www.x-rates.com/table/?from=USD&amount=1.00
Related Posts
International technology Group ANDRITZ has signed a contract for the acquisition of Novimpianti Drying Technology S.r.l., a company owned by Novigroup S.r.l. and based in Lucca, Italy. Novimpianti has approximately 40 employees and generates annual sales of approximately 10 million euros. Novimpianti is a global supplier of engineered equipment and services for air and energy systems to the paper industry’s leading manufacturers. For ANDRITZ, the acquisition of Novimpianti further strengthens its product offerings in the field of air and energy systems, mainly for tissue and paperboard machines. Click Read More below for additional information.
Futures fell for a second day as U.S. crude stockpiles were seen expanding for the first time in 11 weeks, ending a record run of declines. A sharp contraction in…
The American Forest & Paper Association (AF&PA) is calling on the Office of the United States Trade Representative (USTR) to exempt Brazilian bleached eucalyptus kraft pulp (HTS code: 4703.29) from potential Section 301 tariffs, warning that the material is indispensable to the U.S. tissue industry and cannot be purchased domestically at commercial scale. The group submitted its comments as part of USTR’s ongoing investigation into Brazil’s trade practices.
On September 3, USTR will hold a public hearing to gather further testimony on these issues and assess how Brazilian laws may be restricting fair market access for American firms.
AF&PA’s urges that eucalyptus production is extremely limited, with viable growing areas confined to small regions in coastal California and Hawaii, which cannot meet industrial-scale demand.
The association holds that imposing tariffs on Brazilian pulp would harm U.S. manufacturers by raising input costs, reducing profitability, and undermining the competitiveness of American-made tissue products.